Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001437:Bacteriuria / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use* / Q000652:urine; D002512:Cephalothin / Q000494:pharmacology; D002648:Child; D003967:Diarrhea / Q000209:etiology; D004754:Enterobacter / Q000187:drug effects; D004802:Eosinophilia / Q000139:chemically induced; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins; D002512:Cephalothin